Here are six ways to effectively implement glucagon-like peptide-1 agonists (commonly referred to as GLP-1s), including Zepbound, into sleep medicine
The microplate was shaken for 2 min on an orbital plate shaker and was afterwards incubated for 10 min at RT
A patient who has plateaued on semaglutide 2.4 mg or who experienced intolerable side effects on semaglutide may be a candidate for transition to tirzepatide
Studies show 1,500 milligrams, in divided doses throughout the day, can help relieve nausea
NCT, National Clinical Trial
Michael Greger, M.D., FACLM, is a physician, New York Times best-selling author, founder of NutritionFacts.org, and a founding member and Fellow of the American College of Lifestyle Medicine, and internationally recognized speaker on nutrition, food safety, and public health issues